Lectures (Video)
- 1. What Is Biomedical Engineering?
- 2. What Is Biomedical Engineering? (cont.)
- 3. Genetic Engineering
- 4. Genetic Engineering (cont.)
- 5. Cell Culture Engineering
- 6. Cell Culture Engineering (cont.)
- 7. Cell Communication and Immunology
- 8. Cell Communication and Immunology (cont.)
- 9. Biomolecular Engineering: Engineering of Immunity
- 10. Biomolecular Engineering: Engineering of Immunity (cont.)
- 11. Biomolecular Engineering: General Concepts
- 12. Biomolecular Engineering: General Concepts (cont.)
- 13. Cardiovascular Physiology
- 14. Cardiovascular Physiology (cont.)
- 15. Cardiovascular Physiology (cont.)
- 16. Renal Physiology
- 17. Renal Physiology (cont.)
- 18. Biomechanics and Orthopedics
- 19. Biomechanics and Orthopedics (cont.)
- 20. Bioimaging
- 21. Bioimaging (cont.)
- 22. Tissue Engineering
- 23. Tissue Engineering (cont.)
- 24. Biomedical Engineers and Cancer
- 25. Biomedical Engineers and Artificial Organs
Frontiers of Biomedical Engineering - Lecture 11
|
Get the Flash Player to view video.
Lecture 11 - Biomolecular Engineering: General Concepts
Professor Saltzman starts the lecture with an introduction to pharmacokinetics and pharmacodynamics. Professor Saltzman talks about the concept of dose-response. He introduces different routes of drug administration and how they affect drug distribution and bioavailability (i.e., intravenous, oral, and sublingual routes). First-pass drug metabolism by the liver is also identified as an important source of drug degradation. Finally, modeling the body as a well-stirred vessel, Professor Saltzman explains the first-order rate equation: C = (M0/V)*e-kt, that can be used calculate the amount of drug in the body (M) as a function of time (t) and a rate constant (k); and the equation for drug half-life: t = ln(2/k).
Prof. W. Mark Saltzman
BENG 100 Frontiers of Biomedical Engineering, Spring 2008 (Yale University: Open Yale) http://oyc.yale.edu Date accessed: 2009-01-06 License: Creative Commons BY-NC-SA |


